US Stock MarketDetailed Quotes

RVNC Revance Therapeutics

Watchlist
  • 5.280
  • +0.080+1.54%
Close Oct 16 16:00 ET
  • 5.276
  • -0.004-0.08%
Post 16:11 ET
550.07MMarket Cap-1639P/E (TTM)

Revance Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Revance Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 87.977M--
--2024/Q3-- / 68.175M--
Aug 8, 20242024/Q265.389M / 66.290M--
May 9, 20242024/Q151.936M / 56.658M--
Feb 28, 20242023/Q469.799M / 62.098M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 87.977M--
--2024/Q3-- / 68.175M--
Aug 8, 20242024/Q265.389M / 66.290M--
May 9, 20242024/Q151.936M / 56.658M--
Feb 28, 20242023/Q469.799M / 62.098M--

Unlock Free Earnings Estimates

Revance Therapeutics Earnings Reports

  • Revance Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 8 16:40 ET

  • Revance Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 9 16:42 ET

  • Revance Therapeutics | 10-K: FY2023 Annual Report

    Feb 28 22:37 ET

  • Revance Therapeutics | 10-Q: Q3 2023 Earnings Report

    Nov 8, 2023 16:33 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 14, 2024

    Hold

    • Buy

      10.00%

    • Hold

      90.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data